{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:51:00Z","timestamp":1772599860091,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":41,"publisher":"Springer New York","isbn-type":[{"value":"9781493973118","type":"print"},{"value":"9781493973125","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7312-5_20","type":"book-chapter","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T04:45:33Z","timestamp":1505709933000},"page":"239-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polyester-Based Nanoparticles for the Encapsulation of Monoclonal Antibodies"],"prefix":"10.1007","author":[{"given":"Fl\u00e1via","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Fonte","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Patrick J.","family":"Kennedy","sequence":"additional","affiliation":[]},{"given":"In\u00eas Mendes","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"issue":"4","key":"20_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrc3236","volume":"12","author":"AM Scott","year":"2012","unstructured":"Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278\u2013287","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"20_CR2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/aps.2010.120","volume":"31","author":"J Li","year":"2010","unstructured":"Li J, Zhu Z (2010) Research and development of next generation of antibody-based therapeutics. Acta Pharmacol Sin 31(9):1198\u20131207","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"20_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/19420862.2015.989042","volume":"7","author":"DM Ecker","year":"2015","unstructured":"Ecker DM, Jones SD, Levine HL (2015) The therapeutic monoclonal antibody market. mAbs 7(1):9\u201314","journal-title":"mAbs"},{"issue":"2","key":"20_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"P Chames","year":"2009","unstructured":"Chames P, Van Regenmortel M, Weiss E, Baty D (2009) Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157(2):220\u2013233","journal-title":"Br J Pharmacol"},{"issue":"1","key":"20_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bmb\/lds032","volume":"104","author":"H Modjtahedi","year":"2012","unstructured":"Modjtahedi H, Ali S, Essapen S (2012) Therapeutic application of monoclonal antibodies in cancer: advances and challenges. Br Med Bull 104(1):41\u201359","journal-title":"Br Med Bull"},{"issue":"2","key":"20_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cncr.22402","volume":"109","author":"RA Beckman","year":"2007","unstructured":"Beckman RA, Weiner LM, Davis HM (2007) Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer 109(2):170\u2013179","journal-title":"Cancer"},{"issue":"12","key":"20_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","volume":"60","author":"GM Thurber","year":"2008","unstructured":"Thurber GM, Schmidt MM, Wittrup KD (2008) Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. Adv Drug Deliv Rev 60(12):1421","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"20_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/07853890802698842","volume":"41","author":"H Samaranayake","year":"2009","unstructured":"Samaranayake H, Wirth T, Schenkwein D, Raty JK, Yla-Herttuala S (2009) Challenges in monoclonal antibody-based therapies. Ann Med 41(5):322\u2013331","journal-title":"Ann Med"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1155\/2009\/439389","volume":"2009","author":"M Arruebo","year":"2009","unstructured":"Arruebo M, Valladares M, Gonz\u00e1lez-Fern\u00e1ndez \u00c1 (2009) Antibody-conjugated nanoparticles for biomedical applications. J Nanomater 2009:24","journal-title":"J Nanomater"},{"key":"20_CR10","volume-title":"Handbook of polyester drug delivery systems","author":"M Ravikumar","year":"2016","unstructured":"Ravikumar M (2016) Handbook of polyester drug delivery systems. Pan Stanford, USA"},{"key":"20_CR11","first-page":"3071","volume":"8","author":"E Marin","year":"2013","unstructured":"Marin E, Brice\u00f1o MI, Caballero-George C (2013) Critical evaluation of biodegradable polymers used in nanodrugs. Int J Nanomedicine 8:3071\u20133091","journal-title":"Int J Nanomedicine"},{"issue":"3\u20134","key":"20_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejps.2013.07.014","volume":"50","author":"R Varshochian","year":"2013","unstructured":"Varshochian R, Jeddi-Tehrani M, Mahmoudi AR, Khoshayand MR, Atyabi F, Sabzevari A, Esfahani MR, Dinarvand R (2013) The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments. Eur J Pharm Sci 50(3\u20134):341\u2013352","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"20_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijpharm.2008.09.061","volume":"368","author":"S Son","year":"2009","unstructured":"Son S, Lee WR, Joung YK, Kwon MH, Kim YS, Park KD (2009) Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles. Int J Pharm 368(1\u20132):178\u2013185","journal-title":"Int J Pharm"},{"issue":"7","key":"20_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1517\/14712598.4.7.1029","volume":"4","author":"DW Grainger","year":"2004","unstructured":"Grainger DW (2004) Controlled-release and local delivery of therapeutic antibodies. Expert Opin Biol Ther 4(7):1029\u20131044","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"20_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.peptides.2010.10.003","volume":"32","author":"SC Yadav","year":"2011","unstructured":"Yadav SC, Kumari A, Yadav R (2011) Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation. Peptides 32(1):173\u2013187","journal-title":"Peptides"},{"issue":"19","key":"20_CR16","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.2174\/092986712800784667","volume":"19","author":"MM Cardoso","year":"2012","unstructured":"Cardoso MM, Peca IN, Roque AC (2012) Antibody-conjugated nanoparticles for therapeutic applications. Curr Med Chem 19(19):3103\u20133127","journal-title":"Curr Med Chem"},{"issue":"9","key":"20_CR17","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1021\/mp3005935","volume":"10","author":"AR Srinivasan","year":"2013","unstructured":"Srinivasan AR, Lakshmikuttyamma A, Shoyele SA (2013) Investigation of the stability and cellular uptake of self-associated monoclonal antibody (MAb) nanoparticles by non-small lung cancer cells. Mol Pharm 10(9):3275\u20133284","journal-title":"Mol Pharm"},{"issue":"1","key":"20_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","volume":"2","author":"C Pinto Reis","year":"2006","unstructured":"Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation: I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2(1):8\u201321","journal-title":"Nanomedicine"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/1874364101206010054","volume":"6","author":"F Li","year":"2012","unstructured":"Li F, Hurley B, Liu Y, Leonard B, Griffith M (2012) Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration. Open Ophthalmol J 6:54\u201358","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"20_CR20","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.3390\/ijms16023990","volume":"16","author":"A Gdowski","year":"2015","unstructured":"Gdowski A, Ranjan A, Mukerjee A, Vishwanatha J (2015) Development of biodegradable nanocarriers loaded with a monoclonal antibody. Int J Mol Sci 16(2):3990\u20133995","journal-title":"Int J Mol Sci"},{"issue":"6","key":"20_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.addr.2007.04.007","volume":"59","author":"A Almeida","year":"2007","unstructured":"Almeida A, Souto E (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59(6):478\u2013490","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"20_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.02.014","volume":"314","author":"SA Shoyele","year":"2006","unstructured":"Shoyele SA, Slowey A (2006) Prospects of formulating proteins\/peptides as aerosols for pulmonary drug delivery. Int J Pharm 314(1):1\u20138","journal-title":"Int J Pharm"},{"issue":"10","key":"20_CR23","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1021\/bm5010383","volume":"15","author":"P Fonte","year":"2014","unstructured":"Fonte P, Soares S, Sousa F, Costa A, Seabra V, Reis S, Sarmento B (2014) Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles. Biomacromolecules 15(10):3753\u20133765","journal-title":"Biomacromolecules"},{"issue":"2","key":"20_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejps.2009.06.001","volume":"38","author":"A Hawe","year":"2009","unstructured":"Hawe A, Kasper JC, Friess W, Jiskoot W (2009) Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Eur J Pharm Sci 38(2):79\u201387","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"20_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejpb.2006.09.005","volume":"65","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Ferreira DC, Jorgensen L, van de Weert M (2007) Probing insulin\u2019s secondary structure after entrapment into alginate\/chitosan nanoparticles. Eur J Pharm Biopharm 65(1):10\u201317","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"20_CR26","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1038\/nprot.2006.202","volume":"1","author":"NJ Greenfield","year":"2006","unstructured":"Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1(6):2876\u20132890","journal-title":"Nat Protoc"},{"issue":"3","key":"20_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4161\/mabs.2.3.11791","volume":"2","author":"D Chelius","year":"2010","unstructured":"Chelius D, Ruf P, Pl\u00f6scher M, Liedtke R, Gansberger E, Hess J, Wasiliu M, Lindhofer H (2010) Structural and functional characterization of the trifunctional antibody catumaxomab. mAbs 2(3):309\u2013319","journal-title":"mAbs"},{"issue":"9\u201310","key":"20_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/biot.200800091","volume":"3","author":"P Garidel","year":"2008","unstructured":"Garidel P, Hegyi M, Bassarab S, Weichel M (2008) A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy. Biotechnol J 3(9\u201310):1201\u20131211","journal-title":"Biotechnol J"},{"issue":"12","key":"20_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144454","volume":"10","author":"C Oliveira Silva","year":"2015","unstructured":"Oliveira Silva C, Petersen SB, Pinto Reis C, Rijo P, Molpeceres J, Vorum H, Neves-Petersen MT (2015) Lysozyme photochemistry as a function of temperature. The protective effect of nanoparticles on lysozyme photostability. PLoS One 10(12):e0144454","journal-title":"PLoS One"},{"issue":"8","key":"20_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc2403","volume":"8","author":"LM Ellis","year":"2008","unstructured":"Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8(8):579\u2013591","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"20_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","volume":"7","author":"Y Wang","year":"2004","unstructured":"Wang Y, Fei D, Vanderlaan M, Song A (2004) Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. Angiogenesis 7(4):335\u2013345","journal-title":"Angiogenesis"},{"issue":"12","key":"20_CR32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871\u2013882","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"20_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber H-P, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3(5):391\u2013400","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"20_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1755-3768.2008.01257.x","volume":"87","author":"A Carneiro","year":"2009","unstructured":"Carneiro A, Falcao M, Azevedo I, Falcao Reis F, Soares R (2009) Multiple effects of bevacizumab in angiogenesis: implications for its use in age-related macular degeneration. Acta Ophthalmol 87(5):517\u2013523","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"20_CR35","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.acthis.2012.01.006","volume":"114","author":"JC Stockert","year":"2012","unstructured":"Stockert JC, Bl\u00e1zquez-Castro A, Ca\u00f1ete M, Horobin RW, Villanueva \u00c1 (2012) MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem 114(8):785\u2013796","journal-title":"Acta Histochem"},{"key":"20_CR36","unstructured":"Cell Proliferation ELISA, BrdU (colorimetric). Roche Diagnostics, Mannheim, Germany. \n                    http:\/\/www.sigmaaldrich.com\/catalog\/product\/roche\/11647229001?lang=en&region=NO\n                    \n                  . Accessed 10 July 2016"},{"issue":"2","key":"20_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/03639040802235894","volume":"35","author":"K Shi","year":"2009","unstructured":"Shi K, Cui F, Yamamoto H, Kawashima Y (2009) Optimized formulation of high-payload PLGA nanoparticles containing insulin\u2013lauryl sulfate complex. Drug Dev Ind Pharm 35(2):177\u2013184","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"20_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","volume":"133","author":"E Cohen-Sela","year":"2009","unstructured":"Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G (2009) A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release 133(2):90\u201395","journal-title":"J Control Release"},{"issue":"4","key":"20_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1389203003381315","volume":"1","author":"SM Kelly","year":"2000","unstructured":"Kelly SM, Price NC (2000) The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci 1(4):349\u2013384","journal-title":"Curr Protein Pept Sci"},{"issue":"4","key":"20_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1021\/bi951576h","volume":"35","author":"SY Tetin","year":"1996","unstructured":"Tetin SY, Linthicum DS (1996) Circular dichroism spectroscopy of monoclonal antibodies that bind a superpotent guanidinium sweetener ligand. Biochemistry 35(4):1258\u20131264","journal-title":"Biochemistry"},{"issue":"23","key":"20_CR41","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1021\/ac503140j","volume":"86","author":"V Joshi","year":"2014","unstructured":"Joshi V, Shivach T, Yadav N, Rathore AS (2014) Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal antibody therapeutics. Anal Chem 86(23):11606\u201311613","journal-title":"Anal Chem"}],"container-title":["Methods in Molecular Biology","Recombinant Glycoprotein Production"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7312-5_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:32:06Z","timestamp":1558063926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7312-5_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"ISBN":["9781493973118","9781493973125"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7312-5_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"assertion":[{"value":"19 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}